R R

What Is Goldmann-Favre Syndrome?

Goldmann-Favre syndrome is a rare inherited retinal disorder marked by reduced night vision, retinal degeneration, and abnormal foveal structure. People with the condition often notice dim vision from childhood. Over time, central and peripheral clarity may decline. Exams show characteristic retinal cysts and changes in the macular area. Diagnosis typically involves detailed imaging and genetic testing.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Goldmann-Favre Syndrome?

Goldmann-Favre syndrome is a rare inherited retinal disorder marked by reduced night vision, retinal degeneration, and abnormal foveal structure. People with the condition often notice dim vision from childhood. Over time, central and peripheral clarity may decline. Exams show characteristic retinal cysts and changes in the macular area. Diagnosis typically involves detailed imaging and genetic testing.

read more about goldmann favre syndrome ...

Copy this HTML:

Copy HTML Copied!

What Causes Goldmann-Favre Syndrome?

This disorder results from genetic changes that disrupt retinal cell communication. The retina becomes structurally unstable as cysts and degenerative changes form. Night vision declines early because rod cells function poorly. Central vision can also change as the macula becomes disrupted. Family history helps support the diagnosis.

What Symptoms Are Common?

  • Poor night vision from early life.
  • Reduced central and peripheral clarity.
  • Retinal cysts visible on imaging.
  • Macular structural changes.

How Do Doctors Diagnose Goldmann-Favre Syndrome?

They use OCT, ERG testing, and fundus exams to study retinal behavior. Genetic testing confirms the disorder. Doctors track how the retina changes over time. Results guide discussion about expectations and support tools. Regular monitoring helps follow progression.

How Does Goldmann-Favre Syndrome Affect Night Vision and Central Detail Together?

Goldmann-Favre syndrome often affects rod function early, so dim settings become challenging from childhood. Over time, structural changes like retinal cysts and foveal disruption can also affect central clarity, which can show up as blur or reduced detail even in good lighting. Imaging and ERG testing help separate what is happening structurally from what is happening functionally. Monitoring helps track both peripheral and central changes so support tools can be updated as needs shift.

Frequently Asked Questions

Does it begin in childhood?

Yes, many people notice dim night vision early in life. Exams reveal structural changes. Doctors track progression over time. Testing supports long-term planning.

Can the condition progress?

Progression varies widely. Imaging shows how retinal structure shifts. Exams document functional changes. Care focuses on support strategies.

Are both eyes affected?

Yes, both eyes typically show similar patterns. Findings may differ slightly. Exams track each eye separately. Monitoring continues at follow-ups.

Can glasses fix the vision loss?

Standard glasses cannot correct the retinal changes. Support tools help with daily tasks. Doctors explain what to expect. Plans adapt as the condition evolves.

References

A Rare Vitreoretinal Degenerative Disorder: Goldmann?Favre Syndrome. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC11899382/. Date Accessed March 20, 2026.

Goldmann-Favre Syndrome: Case Series. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC5854860/. Date Accessed March 20, 2026.

Clinical Features of Goldmann-Favre Syndrome. PubMed. https://pubmed.ncbi.nlm.nih.gov/10463423/. Date Accessed March 20, 2026.

Goldmann-Favre Syndrome. Orphanet. https://www.orpha.net/en/disease/detail/53540. Date Accessed March 20, 2026.

A Novel Mutation in the NR2E3 Gene Associated with Goldmann-Favre Syndrome and Vasoproliferative Tumor of the Retina. PubMed. https://pubmed.ncbi.nlm.nih.gov/24891813/. Date Accessed March 20, 2026.